(PRPO) – Accesswire
-
Precipio Announces First IV-Cell Commercial Order from Northwell Health
-
Precipio Announces the Resignation of Samuel Riccitelli and the Introduction of Richard Sandberg to its Board of Directors
-
Precipio Wins $750,000 Pharma Project
-
Precipio Reports Superior Performance For IV-Cell(TM) In Side-By-Side Analysis Conducted by Two Major External Laboratories
-
Precipio Announces Q3-2019 Corporate Update Call for Shareholders
-
Partners HealthCare and Precipio Enter into Pathology Services Agreement
-
Precipio Announces Shareholder Update Call on Commercial Progress
Back to PRPO Stock Lookup